Aerosol Delivery and Humidification With the Boussignac Continuous Positive Airway Pressure Device

BACKGROUND: A simple method for effective bronchodilator aerosol delivery while administering continuing continuous positive airway pressure (CPAP) would be useful in patients with severe bronchial obstruction. OBJECTIVE: To assess the effectiveness of bronchodilator aerosol delivery during CPAP generated by the Boussignac CPAP system and its optimal humidification system. METHODS: First we assessed the relationship between flow and pressure generated in the mask with the Boussignac CPAP system. Next we measured the inspired-gas humidity during CPAP, with several humidification strategies, in 9 healthy volunteers. We then measured the bronchodilator aerosol particle size during CPAP, with and without heat-and-moisture exchanger, in a bench study. Finally, in 7 patients with acute respiratory failure and airway obstruction, we measured work of breathing and gas exchange after a β2-agonist bronchodilator aerosol (terbutaline) delivered during CPAP or via standard nebulization. RESULTS: Optimal humidity was obtained only with the heat-and-moisture exchanger or heated humidifier. The heat-and-moisture exchanger had no influence on bronchodilator aerosol particle size. Work of breathing decreased similarly after bronchodilator via either standard nebulization or CPAP, but PaO2 increased significantly only after CPAP aerosol delivery. CONCLUSIONS: CPAP bronchodilator delivery decreases the work of breathing as effectively as does standard nebulization, but produces a greater oxygenation improvement in patients with airway obstruction. To optimize airway humidification, a heat-and-moisture exchanger could be used with the Boussignac CPAP system, without modifying aerosol delivery.

[1]  Arzu Ari,et al.  Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. , 2010, Respiratory care.

[2]  M. Sebbane,et al.  Discomfort associated with underhumidified high-flow oxygen therapy in critically ill patients , 2009, Intensive Care Medicine.

[3]  L. Brochard,et al.  Water content of delivered gases during non-invasive ventilation in healthy subjects , 2009, Intensive Care Medicine.

[4]  J. Benichou,et al.  Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial. , 2007, Annals of emergency medicine.

[5]  G. Liistro,et al.  Effect of continuous positive airway pressure combined to nebulization on lung deposition measured by urinary excretion of amikacin. , 2007, Respiratory medicine.

[6]  V. Parreira,et al.  Nebulization associated with bi-level noninvasive ventilation: analysis of pulmonary radioaerosol deposition. , 2006, Respiratory medicine.

[7]  R. Fernandez,et al.  Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. , 2005, JAMA.

[8]  P. Zeitlin,et al.  Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis. , 2005, Respiratory care.

[9]  V. Ranieri,et al.  Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial. , 2005, JAMA.

[10]  M. Polkey,et al.  Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD , 2004, Thorax.

[11]  G. Liistro,et al.  Comparison of lung deposition in two types of nebulization: intrapulmonary percussive ventilation vs jet nebulization. , 2004, Chest.

[12]  G. Smaldone,et al.  Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. , 2003, American journal of respiratory and critical care medicine.

[13]  D. Hess,et al.  In vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: Effect of ventilator settings and nebulizer position , 2002, Critical care medicine.

[14]  R. Mcevoy,et al.  Effect of CPAP on intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD , 2002, Thorax.

[15]  C. Hamilton,et al.  A comparison of albuterol administered by metered-dose inhaler and spacer with albuterol by nebulizer in adults presenting to an urban emergency department with acute asthma. , 2002, Chest.

[16]  R. Pauwels,et al.  Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals. , 2001, American journal of respiratory and critical care medicine.

[17]  S. Nava,et al.  Salbutamol delivery during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease: a randomized, controlled study , 2001, Intensive Care Medicine.

[18]  A. Harf,et al.  Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study. , 2000, American journal of respiratory and critical care medicine.

[19]  L. Brochard,et al.  Airway Occlusion Pressure to Titrate Positive End-expiratory Pressure in Patients with Dynamic Hyperinflation , 2000, Anesthesiology.

[20]  C. Rodrigo,et al.  First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. , 2000, American journal of respiratory and critical care medicine.

[21]  B. Paluch.  Efficiency and safety of mechanical ventilation with a heat and moisture exchanger changed only once a week , 2000 .

[22]  D. Dreyfuss,et al.  Efficiency and safety of mechanical ventilation with a heat and moisture exchanger changed only once a week. , 2000, American journal of respiratory and critical care medicine.

[23]  A. Bersten,et al.  Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. , 1997, Thorax.

[24]  P. Cistulli,et al.  Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. , 1996, American journal of respiratory and critical care medicine.

[25]  C. Pollack,et al.  Treatment of acute bronchospasm with beta-adrenergic agonist aerosols delivered by a nasal bilevel positive airway pressure circuit. , 1995, Annals of emergency medicine.

[26]  L. Brochard,et al.  Expiratory muscle activity increases intrinsic positive end-expiratory pressure independently of dynamic hyperinflation in mechanically ventilated patients. , 1995, American journal of respiratory and critical care medicine.

[27]  L. Brochard,et al.  Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. , 1994, American journal of respiratory and critical care medicine.

[28]  C F Donner,et al.  Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[29]  V. Ranieri,et al.  Physiologic effects of positive end-expiratory pressure in patients with chronic obstructive pulmonary disease during acute ventilatory failure and controlled mechanical ventilation. , 1993, The American review of respiratory disease.

[30]  A D Bersten,et al.  Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. , 1991, The New England journal of medicine.

[31]  R. Dahl,et al.  Treatment of bronchial asthma with terbutaline inhaled by conespacer combined with positive expiratory pressure mask. , 1991, Chest.

[32]  H. Lorino,et al.  Effects of albuterol inhalation on the work of breathing during weaning from mechanical ventilation. , 1991, The American review of respiratory disease.

[33]  C. K. Mahutte,et al.  Pressure-time product during continuous positive airway pressure, pressure support ventilation, and T-piece during weaning from mechanical ventilation. , 1991, The American review of respiratory disease.

[34]  J. Milic-Emili,et al.  Continuous positive airway pressure reduces work of breathing and dyspnea during weaning from mechanical ventilation in severe chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[35]  Robert J. Taylor,et al.  NEBULISED SALBUTAMOL WITH AND WITHOUT IPRATROPIUM BROMIDE IN ACUTE AIRFLOW OBSTRUCTION , 1989, The Lancet.

[36]  J. Marini,et al.  Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. , 1989, Journal of applied physiology.

[37]  D. Pavia,et al.  Factors influencing the size distribution of aerosols from jet nebulisers. , 1983, Thorax.

[38]  D. Pavia,et al.  ASSESSMENT OF JET NEBULISERS FOR LUNG AEROSOL THERAPY , 1983, The Lancet.

[39]  W A Zin,et al.  A simple method for assessing the validity of the esophageal balloon technique. , 2015, The American review of respiratory disease.

[40]  P E Pepe,et al.  Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. , 1982, The American review of respiratory disease.

[41]  M. Newhouse,et al.  Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. , 1977, The American review of respiratory disease.